Thyrocare Technologies has made an additional investment of $4,75,000 (equivalent to Rs 4.32 crore) in Thyrocare Laboratories (Tanzania) (Thyrocare Tanzania), subsidiary of the company by subscribing to Compulsorily Convertible Irredeemable Preference Shares (CCPS). 

The total investment made by the Company till date (including this tranche of $4,75,000) amounts to $11,50,020 (equivalent to Rs 10.01 crore). The remaining capital infusion will be made by the company in one or more tranches, depending on Thyrocare Tanzania’s business requirements. 

The capital infusion in Thyrocare Tanzania has been made to facilitate its business operations and working capital requirements. Thyrocare Tanzania's business is similar to the company’s main line of business viz. diagnostic and healthcare services.

Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally.